🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsLab Results & BiomarkersThyroid function monitoring on GLP-1 — what worked for you? Page 2

Thyroid function monitoring on GLP-1 — what worked for you?

fiona_VT Mon, May 5, 2025 at 8:59 PM 9 replies 1,432 viewsPage 2 of 2
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
May 6, 2025 at 1:01 PM#6
that TPO antibody reduction is really interesting. There's actually a 2024 study in *Thyroid* journal (doi: 10.1089/thy.2023.0412) showing GLP-1 RAs reduced TPO antibodies by a mean of 31% in Hashimoto's patients over 12 months. The proposed mechanism is reduction in visceral adipose tissue, which is a major source of inflammatory cytokines that drive thyroid autoimmunity. Your 43% reduction in 9 months exceeds their average, probably because you're also getting the anti-inflammatory benefits of significant weight loss.
43 13ingrid_STO, pete_nash, hank_denver and 40 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
May 6, 2025 at 7:23 PM#7
I have a family history of thyroid cancer (my aunt had papillary thyroid cancer). My PCP won't prescribe GLP-1 because of the black box warning. Is this warranted or should I get a second opinion?
42 12bbq_ray_KC, oliver_london, tane_welly and 39 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
May 7, 2025 at 1:45 AM#8
papillary thyroid cancer is NOT medullary thyroid cancer. They are completely different cell types. The black box warning specifically relates to C-cell tumors (medullary thyroid carcinoma / MTC), which arise from calcitonin-producing cells. Papillary thyroid cancer arises from follicular cells and has zero relationship to GLP-1 receptor activation. The contraindication is for: personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Family history of papillary thyroid cancer is NOT a contraindication. I would respectfully suggest getting a second opinion from an endocrinologist who can clarify this distinction. Your PCP may be erring on the side of caution, which is understandable, but in this case the caution is based on a misunderstanding.
41 11kevin_tulsa, Dr.PainCLE, mike_mealprep and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SaraMom3
Member
456
2,345
Aug 2024
Ohio
May 7, 2025 at 8:07 AM#9
Update: Increased my calories to ~1500/day with focus on protein (hitting about 95-100g). Also started selenium 200mcg. Only been a week but I already feel less cold and have slightly more energy. Getting labs rechecked in 6 weeks. Thanks for the reality check everyone — this thread genuinely reduced my anxiety. 🙏
40 10CanadaChris, ZaraB_AL, JakeSmashed95 and 37 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
May 8, 2025 at 2:43 PM#10
Glad to hear it! And also, definitely get that second opinion. The distinction between papillary and medullary thyroid cancer is a really important one that not all PCPs are clear on. An endocrinologist will be able to properly risk-stratify you. Don't let a misunderstanding keep you from a medication that could genuinely help your health.
38 11bbq_ray_KC, oliver_london, tane_welly and 35 others
Reply Quote Save Share Report

Similar Threads

Optimal lab testing frequency on GLP-1 — evidence-based schedule5 replies
A1C from 7.2 to 5.1 — my bloodwork transformation19 replies
Thyroid function monitoring on GLP-1 — TSH and free T4 trends3 replies
Lipid panel improvements mega-thread — share your numbers19 replies
Liver enzymes trending down on GLP-1 — ALT/AST normalization17 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register